report
Brain-computer interface market to be valued at $3.1b by 2030
Brain-computer interface market to be valued at $3.1b by 2030
One driver is the rising demand for neurorehabilitation solutions.
Australia’s oncology devices market to witness 3% CAGR until 2033
It accounted for 10% of the Asia Pacific market in 2024.
Indonesia’s pharma sector to rely on imports despite export boost: report
Imports are forecast to hit $1.6b by 2029, whilst exports are expected to reach $927m.
China's intraocular lens market to see 2% CAGR until 2033
Its expansion is attributed to the rising prevalence of myopia.
Global medical device connectivity market to hit $16.21b by 2032
Thanks to the increasing adoption of telehealth solutions and remote monitoring.
Global healthcare education market to hit $280.6b by 2032
One key driver is the integration of virtual learning platforms.
Musculoskeletal care digital health market to reach $11.6b by 2030
Thanks to the rising prevalence of musculoskeletal conditions.
IHH Healthcare to face “flat earnings” growth in FY25F: report
Its Singapore operations are expected to soften in the same period.
What’s next for the global heparin market?
It is expected to witness a CAGR of 7.22% through 2028.
Global biopsy devices market projected to hit $4.02b by 2033
Thanks to advancements in medical technology.
UAE pharmaceutical market to be valued at $7.9b by 2029
One driver is the new mandatory health insurance scheme for all private sector employees.
Health budget cuts to limit market opportunities in PH public health sector
Public health expenditure will see a 3.5% reduction compared to 2024 levels.
Global DNA sequencing market to witness 18.6% CAGR growth through 2029
However, high costs and data interpretation difficulties pose challenges to the sector.
Ostomy care accessory market to reach $1.3b by 2034
Notable developments include smart sensors and remote monitoring.
Global breast cancer brachytherapy market to be valued at $1.88b by 2035
It is expected to witness a 6.94% CAGR growth during the period.
What factors drive anticoagulant reversal drugs market growth in the APAC?
Countries such as China and India are expected to lead the market.
Thailand’s private hospitals to face modest impact from copayment scheme
It is estimated to have a 1-2% effect on net profit in FY25 and 2-3% in FY26.
Most Read
1. Singapore launches online tool for health insurance planning 2. Asian Hospital’s CyberKnife tracks tumours in real time 3. Prudential Hong Kong introduces ophthalmology direct billing at EKMC 4. NUH, Jaga-Me ink MoU for supportive and palliative care 5. Japan’s medical device market to be valued at $42.9b by 2029Resource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
PicoSure® Pro takes picosecond laser technology to unprecedented levels of performance.
Commentary
Why preventing diseases through adult immunisation is essential to keeping Singaporeans healthy